Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate- 10B conjugates as 10B-carriers in boron neutron capture therapy

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 24, Issue 2, 2006, Pages 98-107

  Masunaga, Shin Ichiro ^a   Nagasawa, Hideko ^b   Gotoh, Keiko ^b   Sakurai, Yoshinori ^a   Uto, Yoshihiro ^b   Hori, Hitoshi ^b   Nagata, Kenji ^a   Suzuki, Minoru ^a   Maruhashi, Akira ^a   Kinashi, Yuko ^a   Ono, Koji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Boron neutron capture therapy; Hypoxic cytotoxin; Quiescent cell; Sodium borocaptate 10B; Thermal neutrons

Indexed keywords

BOROCAPTATE; BROXURIDINE; CYTOCHALASIN B; CYTOTOXIC AGENT; QUINOXALINE DERIVATIVE; RADIOSENSITIZING AGENT; TX 2091; TX 2095; TX 2097; TX 2100; TX 2110; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELL SURVIVAL; CELL SUSPENSION; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; GAMMA SPECTROMETRY; HYPOXIC CELL; IMMUNOFLUORESCENCE; MICRONUCLEUS; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; SQUAMOUS CELL CARCINOMA; TISSUE DISTRIBUTION; TUMOR CELL;

ANIMALS; BOROHYDRIDES; BORON; BORON NEUTRON CAPTURE THERAPY; CARCINOMA, SQUAMOUS CELL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; ISOTOPES; MICE; MOLECULAR STRUCTURE; NITRILES; NITROIMIDAZOLES; QUINOXALINES; SULFHYDRYL COMPOUNDS; TISSUE DISTRIBUTION;

EID: 33645778985     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02493275     Document Type: Article

References (20)

1. Coderre JA, Morris GM. The radiation biology of boron neutron capture therapy. Radiat Res, 151: 1-18, 1999.
2. Masunaga S, Ono K. Significance of the response of quiescent cell populations within solid tumors in cancer therapy. J Radiat Res, 43: 11-25, 2002.
3. Hori H, Jin CZ, Kiyono M, Kasai S, Shimamura M, Inayama S. Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles. Bioorg Med Chem, 5: 591-599, 1997.
4. 10B concentrations in tissue for neutron capture therapy by prompt γ-ray spectrometry. Nucl Instrum Methods, 204: 525-531, 1983.
5. Caswell RS, Coyne JJ, Randolph ML. Kerma factors for neutron energies below 30 MeV. Radiat Res, 83: 217-254, 1980.
6. Sakurai, Y, Kobayashi T. Characteristics of the KUR heavy water neutron irradiation facility as a neutron irradiation field with variable energy spectra. Nucl Instr Meth Phys Res, A453: 569-596, 2000.
7. Ando K, Koike S, Ohira C, et al. Accelerated reoxygenation of a murine fibrosarcoma after carbon-ion radiation. Int J Radiat Biol, 75: 505-512, 1999.
8. Masunaga S, Takahashi A, Ohnishi K, et al. Effects of p53 status and wortmannin treatment on potentially lethal damage repair, with emphasis on the response of intratumor quiescent cells. Radiat Med, 21: 120-127, 2003.
9. Maruyama K, Ishida O, Kasaoka S, et al. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J Control Release, 98: 195-207, 2004.
10. Brown JM. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol Med Today, 6: 157-162, 2000.
11. Rofstad EK. Microenvironment-induced cancer metastasis. Int J Radiat Biol, 76: 589-605, 2000.
12. Brown JM, Wang LH. Tirapazamine: laboratory data relevant to clinical activity. Anticancer Drug Des, 13: 529-539, 1998.
13. Nagasawa H, Yamashita M, Mikamo N, et al. Design, synthesis and biological activities of antiangiogenic hypoxic cytotoxin, triazine-N-oxide derivatives. Comp Biochem Physiol A Mol Integr Physiol, 132: 33-40, 2002.
14. Hall EJ. The oxygen effect and reoxygenation. In Radiobiology for the Radiologist, 5th ed. (Hall EJ ed.; Lippincott Williams & Wilkins, Philadelphia), pp. 91-111, 2000.
15. Masunaga S, Ono K, Sakurai Y, et al. Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios. Int J Radiat Oncol Biol Phys, 41: 1163-70, 1998.
16. Masunaga S, Ono K, Akaboshi M, et al. Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations. Br J Cancer, 76: 588-593, 1997.
17. Masunaga S, Ono K, Sakurai Y, et al. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors. Int J Radiat Oncol Biol Phys, 51: 828-839, 2001.
18. 10B-carrier in boron neutron capture therapy. Anticancer Res, 24: 2975-2983, 2004.
19. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res, 58: 1408-1416, 1998.
20. Vaupel P, Kelleher DK, Hoeckel M. Oxygenation status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol, 28 (2 Suppl 8): 29-35, 2001.